Moderna
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
CEOStéphane Bancel
CEOStéphane Bancel
Employees5,800
Employees5,800
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees5,800
Employees5,800
MRNA Key Statistics
Market cap11.80B
Market cap11.80B
Price-Earnings ratio-3.47
Price-Earnings ratio-3.47
Dividend yield—
Dividend yield—
Average volume10.23M
Average volume10.23M
High today$30.94
High today$30.94
Low today$30.20
Low today$30.20
Open price$30.55
Open price$30.55
Volume1.91M
Volume1.91M
52 Week high$129.39
52 Week high$129.39
52 Week low$23.15
52 Week low$23.15
MRNA News
Seeking Alpha 3d
Moderna reports effective results from influenza vaccine trialModerna (NASDAQ:MRNA), on Monday, reported positive results from a late-stage study comparing its influenza vaccine candidate, mRNA-1010, to a standard vaccine...
Sherwood News 3d
Moderna rises after positive flu vaccine trial results, paving way for combo shotModerna rises after positive flu vaccine trial results, paving way for combo shot Modernarose more than 5% in premarket trading after announcing positive resul...
Analyst ratings
64%
of 28 ratingsBuy
21.4%
Hold
64.3%
Sell
14.3%
People also own
Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.